ArticleProceedings of the National Academy of Sciences of the United States of America2023

Engineered bone marrow as a clinically relevant ex vivo model for primary bone cancer research and drug screening.

Katherine H Griffin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.